FibroGen Stock Jump On Thursday, Outperforms Market

(VIANEWS) – The NASDAQ ended the session with FibroGen (FGEN) rising 10% to $0.89 on Thursday while NASDAQ dropped 0.03% to $15,095.14. FibroGen’s last close was $0.81, 96.85% under its 52-week high of $25.69. About FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product…

Read More

DouYu And Canaan On The List Of Winners And Losers Of Thursday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are DouYu, ParkerVision, and FibroGen. Rank Financial Asset Price Change Updated (EST) 1 DouYu (DOYU) 0.90 22.94% 2023-12-28 12:16:10 2 ParkerVision (PRKR) 0.18 20% 2023-12-28 09:14:06…

Read More